Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities

Front Pharmacol. 2022 Nov 21:13:1080645. doi: 10.3389/fphar.2022.1080645. eCollection 2022.

¹ The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd, Tianjin, China.
² PriMed Non-Human Primate Research Center of Sichuan PriMed Shines Bio-Tech Co., Ltd., Ya'an, Sichuan, China.
³ China Pharmaceutical University, Nanjing, China.
⁴ Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
⁵ School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.1017433.].

Keywords: QSYQ; SHR; heart failure; metabolomics; network pharmacology.